Instil Bio, Inc. financial data

Symbol
TIL on Nasdaq
Location
3963 Maple Avenue, Suite 350, Dallas, TX
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - May 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.77K % +28.8%
Debt-to-equity 55.7 % +28.2%
Return On Equity -45.5 % +11.2%
Return On Assets -29.2 % +18.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.53M shares +0.34%
Common Stock, Shares, Outstanding 6.56M shares +0.85%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 6.53M shares +0.44%
Weighted Average Number of Shares Outstanding, Diluted 6.53M shares +0.44%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 40.9M USD -12.5%
Operating Income (Loss) -80.1M USD +35.7%
Nonoperating Income (Expense) -2.39M USD -152%
Net Income (Loss) Attributable to Parent -78M USD +36.7%
Earnings Per Share, Basic -12 USD/shares +36.9%
Earnings Per Share, Diluted -12 USD/shares +36.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 15.4M USD +180%
Other Assets, Current 192K USD
Assets, Current 219M USD +36.2%
Operating Lease, Right-of-Use Asset 763K USD -60.6%
Other Assets, Noncurrent 10.1M USD +470%
Assets 237M USD -22.5%
Accounts Payable, Current 286K USD -76.7%
Employee-related Liabilities, Current 898K USD -48.6%
Liabilities, Current 7.23M USD -36.3%
Operating Lease, Liability, Noncurrent 48K USD -98%
Other Liabilities, Noncurrent 85K USD +97.7%
Liabilities 92.5M USD -7.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -451K USD +19.9%
Retained Earnings (Accumulated Deficit) -683M USD -12.9%
Stockholders' Equity Attributable to Parent 145M USD -29.6%
Liabilities and Equity 237M USD -22.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.2M USD +70.9%
Net Cash Provided by (Used in) Financing Activities 232K USD
Net Cash Provided by (Used in) Investing Activities 9.61M USD +3.98%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 6.56M shares +0.85%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 16.3M USD +198%
Interest Paid, Excluding Capitalized Interest, Operating Activities 886K USD -48.8%
Operating Lease, Liability 2.44M USD -40.9%
Depreciation 3.1M USD -22.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -77.9M USD +36.9%
Lessee, Operating Lease, Liability, to be Paid 2.77M USD -37.9%
Property, Plant and Equipment, Gross 509K USD -99.6%
Operating Lease, Liability, Current 2.39M USD +42.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 169K USD -90.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 324K USD +0.31%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Operating Lease, Payments 2.17M USD +10.6%
Additional Paid in Capital 829M USD +2.1%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 498K USD -49.8%
Share-based Payment Arrangement, Expense 16.2M USD -10.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares